Comparative value of thallium and glucose SPECT imaging in childhood brain tumors

Pediatric Neurology

Volumn 19, Issue 5, 1998, Pages 351-357

  Maria, Bernard L ^a,b   Drane, Walter E ^a   Mastin, Suzanne T ^a   Jimenez, Luis A ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; THALLIUM CHLORIDE TL 201;

ADOLESCENT; ARTICLE; BRAIN TUMOR; CHILD; CLINICAL ARTICLE; CONTRAST SENSITIVITY; DIAGNOSTIC VALUE; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR CLASSIFICATION; TUMOR LOCALIZATION; TUMOR RECURRENCE; TUMOR VOLUME;

BRAIN NEOPLASMS; CHILD; FALSE NEGATIVE REACTIONS; FLUORODEOXYGLUCOSE F18; HUMANS; NECROSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; PREDICTIVE VALUE OF TESTS; RADIATION INJURIES; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0032215409     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-8994(98)00083-6     Document Type: Article

References (24)

1. Kaplan W.D., Takvorian T., Morris J.H., Rumbaugh C.L., Connolly B.T., Atkins H.L. Thallium-201 brain tumor imaging A comparative study with pathologic correlation . J Nucl Med. 28:1987;47-52.
2. Tonami N. Thallium-201 SPECT in the evaluation of gliomas. J Nucl Med. 34:1993;2089-2090.
3. Waxman A.D. Thallium-201 in nuclear oncology. Freeman L.M. Nuclear medicine annual. 1991;Raven Press, New York.
4. Di Chiro G. Positron emission tomography using [18F] fluorodeoxyglucose in brain tumors A powerful diagnostic and prognostic tool . Invest Radiol. 22:1986;360-371.
5. Coleman R.E., Hoffman J.M., Hanson M.W., Sostman H.D., Schold S.C. Clinical application of PET for the evaluation of brain tumors. J Nucl Med. 32:1991;616-622.
6. Black K.L., Hawkins R.A., Kim K.T., Becker D.P., Lerner C., Marciano D. Use of thallium SPECT to quantify malignancy grade of gliomas. J Neurosurg. 71:1989;342-346.
7. Di Chiro G., De La Paz R.L., Brooks R.A., et al. Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography. Neurology. 32:1982;1323-1329.
8. Patronas N.J., Di Chiro G., Kufta C., et al. Prediction of survival in glioma patients by means of positron emission tomography. J Neurosurg. 62:1985;816-822.
9. Alavi J.B., Alavi A., Chawluk J., et al. Positron emission tomography in patient with glioma A predictor of prognosis . Cancer. 62:1988;1074-1078.
10. Oriuchi N., Tamura M., Shibazake T., et al. Clinical evaluation of thallium-201 SPECT in supratentorial gliomas Relationship to histologic grade, prognosis, and proliferative activities . J Nucl Med. 34:1993;2085-2089.
11. Waxman A.D., Grode M., Ashok G., Kooba A., Ramanna L. Intraoperative assessment of brain malignancies using Tl-201 (abstract). J Nucl Med. 34:1993;37P.
12. Schwartz R.B., Carvalho P.A., Alexander M.E., Loeffler J.S., Folkerth R., Holman B.L. Radiation necrosis vs. high-grade recurrent glioma Differentiation by using dual-isotope SPECT with 201Tl and 99mTc HMPAO . Am J Neuroradiol. 12:1991;1187-1192.
13. O'Tuama L.A., Janicek M.J., Barnes P.D., et al. 201Tl/99mTc-HMPAO SPECT imaging of treated childhood brain tumors. Pediatr Neurol. 7:1991;249-257.
14. Maria B.L., Drane W.E., Quisling R.G., et al. Value of 201 Thallium SPECT imaging in childhood brain tumors. Pediatr Neurosurg. 20:1994;11-18.
15. Maria B.L., Drane W.E., Quisling R.J., Hoang K.B. Significance of gadolinium-DTPA contrast enhancement and thallium 201 chloride uptake in pediatric brain stem gliomas. J Child Neurol. 12:1997;341-348.
16. Patronas N.J., Di Chiro G., Brooks R.A., et al. Work-in-progress [18F] Fluoro-deoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain . Radiology. 144:1982;885-889.
17. Mountz J.M., Staffard-Schuck K., McKeever P.E., Tarca J., Beierwaltes W.H. Thallium-201 tumor/cardiac ratio estimation of residual astrocytoma. J Neurosurg. 68:1988;705-709.
18. Drane W.E., Abbott F.D., Nicole M.W., Mastin S.T., Kuperus J.H. Technology for FDG SPECT with a relatively inexpensive gamma camera. Radiology. 191:1994;461-465.
19. Brismur J., Roberson G.H., Davis K.R. Radiation necrosis of the brain Neuroradiological consideration with computed tomography . Neuroradiology. 12:1976;109-113.
20. Dooms G.C., Hecht S., Brandt-Zawadski M., Berthiaume Y., Norman D., Newton T.H. Brain radiation lesions MR imaging . Radiology. 158:1986;149-155.
21. Bailet J.W., Abermayor E., Jabour B.A., Hawkins R.A., Ho C., Ward P.H. Positron emission tomography A new, precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathy . Laryngoscope. 102:1992;281-288.
22. Mukherji S.K., Drane W.E., Tart R.P., Landau S., Mancuso A.A. Comparison of thallium-201 and F-18 FDG SPECT uptake in squamous carcinoma of the head and neck. Am J Neuroradiol. 15:1994;1837-1842.
23. Greven K.M., Williams D.W. III, Keyes J.W. Jr, et al. Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation. Cancer. 74:1994;1355-1359.
24. Maria B.L., Drane W.E. SPECT imaging of pediatric brain tumors A comparative study of thallium-201 chloride, F-18 fluoro-deoxyglucose, and 99mTc hexamethyl-propylene-amine-oxime (abstract) . Ann Neurol. 36:1994;505.